At the news
? NEUTRALIMPACT 3/10 6-K filed Jun 29, 2026 at 10:25 ET
GSK completed its £2 billion share buyback program, purchasing 123,939,156 ordinary shares since February 24, 2025. The final tranche of 1,054,653 shares was bought between June 22-26, 2026, at an average price of approximately 1,953.54 GBp per share. This is a routine capital return milestone with no new financial data or strategic changes.
- GSK completed its £2 billion buyback program announced on February 24, 2025.
- Since February 24, 2025, GSK purchased 123,939,156 ordinary shares for aggregate consideration of just under £2 billion.
- The final week (June 22-26, 2026) saw purchases of 1,054,653 shares at volume-weighted average prices between 1,919.89 GBp and 1,967.46 GBp.
- Following purchases, GSK holds 270,881,064 shares in treasury and has 4,045,395,364 shares in issue (excluding treasury).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access